Gainers
- CynergisTek, Inc. (NYSE:CTEK) jumped 100% to $1.18 after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7 million.
- SciSparc Ltd. (NASDAQ:SPRC) gained 62% to $3.70. SciSparc disclosed positive safety profile results from its joint pre-clinical trial with Clearmind Medicine Inc. for its psychedelic combination treatment.
- BIMI International Medical Inc. (NASDAQ:BIMI) shares jumped 30.7% to $0.7905. BOQI International recently posted a Q1 loss of $0.27 per share.
- Better Therapeutics, Inc. (NASDAQ:BTTX) rose 27.9% to $1.65 after dropping 12% on Monday. Better Therapeutics recently posted a Q1 loss of $0.41 per share.
- America's Car-Mart, Inc. (NASDAQ:CRMT) shares jumped 25.6% to $95.67 after reporting better-than-expected Q4 results.
- AppTech Payments Corp. (NASDAQ:APCX) surged 20% to $0.90.
- GeoVax Labs, Inc. (NASDAQ:GOVX) gained 19.4% to $2.7699. GeoVax received a Notice of Allowance for cancer vaccine patent in China.
- Guardforce AI Co., Limited (NASDAQ:GFAI) shares rose 18.8% to $0.7412 after jumping around 14% on Monday.
- Quantum Computing, Inc. (NASDAQ:QUBT) gained 16.5% to $1.8174. Quantum Computing’s 8-K showed that the company and Project Alpha Merger entered deal to buy QPhoton.
- Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 13.9% to $2.71.
- Decisionpoint Systems, Inc. (NYSE:DPSI) shares rose 13.1% to $6.23. DecisionPoint Systems recently reported first-quarter FY22 revenue growth of 22.7% year-on-year to $19.7 million.
- Neonode Inc. (NASDAQ:NEON) jumped 12.3% to $6.28. Neonode recently posted a Q1 loss of $0.10 per share.
- Euroseas Ltd. (NASDAQ:ESEA) gained 10.1% to $30.73 after the company reported better-than-expected Q1 EPS and sales results and announced a stock buyback up to $20 million.
- Beyond Air, Inc. (NASDAQ:XAIR) surged 9.3% to $5.90. Beyond Air recently presented encouraging update from at-home LungFit GO pilot study in lung disease.
- China Liberal Education Holdings Limited (NASDAQ:CLEU) shares gained 9.2% to $2.3157.
- Sono-Tek Corporation (NASDAQ:SOTK) gained 8.5% to $6.53. Sono-Tek posted FY22 sales of $17.1 million.
Losers
- Genocea Biosciences, Inc. (NASDAQ:GNCA) shares tumbled 69.4% to $0.0682 after the company announced it is winding down operations and delisting from NASDAQ.
- MSP Recovery Inc. (NASDAQ:MSPR) shares dipped 63.1% to $3.98. MSP Recovery’s Class A Common Stock and warrants started trading today.
- Snap Inc. (NYSE:SNAP) dropped 40.4% to $13.39. The parent company of Snapchat filed a form 8-K with the U.S. Securities and Exchange Commission to lower its previously-issued guidance for the second quarter. When Snap originally issued its guidance for the quarter on April 21, the company forecast second-quarter revenues to come in 20% to 25% above the same period the year prior.
- BigBear.ai Holdings, Inc. (NYSE:BBAI) dipped 29.7% to $7.11. BigBear.ai Holdings recently posted a Q1 loss of $0.14 per share.
- Abercrombie & Fitch Co. (NYSE:ANF) shares declined 28.6% to $19.07 after the company reported Q1 earnings results and issued guidance.
- Pinterest, Inc. (NYSE:PINS) fell 28.3% to $16.19 after Snap filed a Form 8-K with the U.S. Securities and Exchange Commission showing the company expects to miss its previously-issued guidance.
- INmune Bio, Inc. (NASDAQ:INMB) dropped 26.1% to $5.37 after the company reported the FDA requested additional information around Chemistry Manufacturing and Controls of XPro1595 and placed the IND application to initiate its Phase 2 clinical trial on clinical hold.
- WalkMe Ltd. (NASDAQ:WKME) declined 23.6% to $9.32 following Q1 results.
- Nautilus, Inc. (NYSE:NLS) fell 22.1% to $1.9550 after the company reported worse-than-expected Q4 sales results and issued FY23 sales guidance below analyst estimates.
- Liquidia Corporation (NASDAQ:LQDA) dropped 21.9% to $3.67. Liquidia Technologies recently posted a Q1 loss of $0.30 per share.
- The Trade Desk, Inc. (NASDAQ:TTD) fell 20.2% to $41.89.
- Chimerix, Inc. (NASDAQ:CMRX) dropped 19.7% to $1.8850.
- Studio City International Holdings Limited (NYSE:MSC) dropped 19.4% to $1.87.
- Kala Pharmaceuticals, Inc. (NASDAQ:KALA) tumbled 19.3% to $0.4891 as HC Wainwright & Co. maintained Buy on the stock and lowered price target to $4. Kala Pharmaceuticals said it would sell its EYSUVIS and INVELTYS treatments for $60 million.
- Cango Inc. (NYSE:CANG) fell 19% to $2.95 after gaining around 10% on Monday.
- Agora, Inc. (NASDAQ:API) dropped 18.4% to $5.47 following weak quarterly earnings.
- Purple Innovation, Inc. (NASDAQ:PRPL) declined 17.9% to $4.4650.
- Standard BioTools Inc. (NASDAQ:LAB) fell 17.8% to $2.1350.
- Oscar Health, Inc. (NYSE:OSCR) dipped 17.8% to $4.6650. Oscar Health recently posted a Q1 loss of $0.36 per share.
- TherapeuticsMD, Inc. (NASDAQ:TXMD) fell 17.3% to $2.1150. TherapeuticsMD recently announced that it has received FDA approval of its supplemental New Drug Application for ANNOVERA.
- Avaya Holdings Corp. (NYSE:AVYA) fell 17.1% to $3.4050.
- Roku, Inc. (NASDAQ:ROKU) dropped 17% to $76.15.
- Sprout Social, Inc. (NASDAQ:SPT) dipped 16.6% to $39.78.
- Global Internet of People, Inc. (NASDAQ:SDH) fell 16.3% to $1.39.
- GDS Holdings Limited (NASDAQ:GDS) fell 15.3% to $24.64. GDS Holdings recently posted a Q1 net loss of $58.9 million.
- Full Truck Alliance Co. Ltd. (NYSE:YMM) dropped 15.1% to $4.71.
- Dada Nexus Limited (NASDAQ:DADA) fell 14.8% to $5.58.
- Lyft, Inc. (NASDAQ:LYFT) dipped 14.2% to $17.33. Bernstein assumed Lyft with a Market Perform rating and lowered the price target to $22.
- Fisker Inc. (NYSE:FSR) dropped 13.8% to $9.50. Fisker announced the launch of its $350 million at the market offering program.
- Express, Inc. (NYSE:EXPR) fell 13.4% to $2.5550. Express is expected to release quarterly results on May 25, 2022.
- The Beauty Health Company (NASDAQ:SKIN) fell 9.6% to $11.04.
- Bright Green Corporation (NASDAQ:BGXX) fell 8.8% to $12.11 after jumping 18% on Monday.
- Catalyst Biosciences, Inc. (NASDAQ:CBIO) fell 7.9% to $1.1701. Catalyst Biosciences gained 234% on Monday after the company announced it sold its complement portfolio for $60 million.
- X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) shares fell 7.6% to $1.22 after gaining 12% on Monday.
